Lahoud, Yousef <br/><br/>
Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1.  [electronic resource] 

 -  World journal of urology  Dec 2015 
 - 2053-62 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1433-8726 
<br/><br/><label>Standard No.: </label>10.1007/s00345-015-1579-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Kidney Injury--etiology<br/>Acute-Phase Proteins--metabolism<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers<br/>Carcinoma--pathology<br/>Creatinine--blood<br/>Female<br/>Hepatitis A Virus Cellular Receptor 1<br/>Humans<br/>Ischemia<br/>Kidney Neoplasms--pathology<br/>Lipocalin-2<br/>Lipocalins--metabolism<br/>Male<br/>Membrane Glycoproteins--metabolism<br/>Middle Aged<br/>Nephrectomy--adverse effects<br/>Nephrons<br/>Phosphodiesterase 5 Inhibitors--therapeutic use<br/>Prospective Studies<br/>Proto-Oncogene Proteins--metabolism<br/>Receptors, Virus--metabolism<br/>Tadalafil--therapeutic use